Stock PAIN THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

MarketScreener Editorial Features Pain Therapeutics, Inc. Nasdaq

Equities

US69562K1007

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Pain Therapeutics, Inc.
Mar. 25 Cassava Sciences Announces Completion of Interim Safety Review for Alzheimer's Drug Candidate Simufilam MT
Mar. 25 Cassava Sciences, Inc. Announces Completion of an Interim Safety Review of Oral Simufilam On-Going Phase 3 Trials CI

MarketScreener Editorial Features

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SAVA Stock
  4. Stock
  5. News Pain Therapeutics, Inc.
  6. MarketScreener Editorial Features